» Articles » PMID: 8613353

Dominance of Conserved B-cell Epitopes of the Plasmodium Falciparum Merozoite Surface Protein, MSP1, in Blood-stage Infections of Naive Aotus Monkeys

Overview
Journal Infect Immun
Date 1996 May 1
PMID 8613353
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

We have shown that conserved B epitopes were immunodominant in animals hyperimmunized with parasite-purified or recombinant merozoite surface protein MSP1 of Plasmodium falciparum. Cross-priming studies also suggested that a conserved T-helper epitope(s) is efficient in inducing the anti-MSP1 antibody response. In this study, we determined whether a similar profile of immune responses was induced during live P. falciparum infections. Naive Aotus monkeys were infected by blood-stage challenge with either one of the two dimorphic MSP1 alleles represented by the FUP and FVO parasites. Sera collected after parasite clearance were analyzed by enzyme-linked immunosorbent assays (ELISAs). Monkeys infected with parasites carrying one allelic form of MSP1 had antibodies that were equally reactive with homologous or heterologous MSP1s. This preferential recognition of conserved epitopes of MSP1 was confirmed by competitive binding ELISAs. Studies with Plasmodium yoelii and P. falciparum show that the C-terminal 19-kDa fragment of MSP1, MSP1(19), is the target of protective immunity. Thus, monkey sera were assayed for recognition with recombinant MSP1(19)s expressing variant and conserved B epitopes. Results of direct and competitive binding ELISAs showed that the anti-MSP1(19) antibodies were also directed primarily against conserved determinants. The similarities between vaccine- or infection-induced antibody responses suggest a possible reciprocal enhancement of the two populations of anti-MSP1 antibodies when a subunit MSP1 vaccine is introduced into populations living in areas where malaria is endemic. This together with previous observations that conserved determinants are important in MSP1-mediated immunity provides an optimistic outlook that a subunit MSP1 vaccine may be effective and practical for field applications in malaria-exposed populations.

Citing Articles

Immunogenicity of bacterial-expressed recombinant Plasmodium knowlesi merozoite surface protein-142 (MSP-142).

Cheong F, Fong M, Lau Y, Mahmud R Malar J. 2013; 12:454.

PMID: 24354660 PMC: 3878241. DOI: 10.1186/1475-2875-12-454.


Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-1(19)) in Iranians exposed to unstable malaria transmission.

Zakeri S, Mehrizi A, Zoghi S, Djadid N Malar J. 2010; 9:257.

PMID: 20846388 PMC: 2945361. DOI: 10.1186/1475-2875-9-257.


The Plasmodium falciparum merozoite surface protein-1 19 KD antibody response in the Peruvian Amazon predominantly targets the non-allele specific, shared sites of this antigen.

Sutton P, Clark E, Silva C, Branch O Malar J. 2010; 9:3.

PMID: 20047674 PMC: 2818648. DOI: 10.1186/1475-2875-9-3.


Growth-inhibitory antibodies are not necessary for protective immunity to malaria infection.

Murhandarwati E, Wang L, de Silva H, Ma C, Plebanski M, Black C Infect Immun. 2009; 78(2):680-7.

PMID: 19917716 PMC: 2812185. DOI: 10.1128/IAI.00939-09.


Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission.

Torres K, Clark E, Hernandez J, Soto-Cornejo K, Gamboa D, Branch O Malar J. 2008; 7:173.

PMID: 18782451 PMC: 2557017. DOI: 10.1186/1475-2875-7-173.


References
1.
Holder A, Freeman R . The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor. J Exp Med. 1984; 160(2):624-9. PMC: 2187444. DOI: 10.1084/jem.160.2.624. View

2.
Chang S, Case S, Gosnell W, Hashimoto A, Kramer K, Tam L . A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infect Immun. 1996; 64(1):253-61. PMC: 173753. DOI: 10.1128/iai.64.1.253-261.1996. View

3.
Tanabe K, Mackay M, Goman M, Scaife J . Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. J Mol Biol. 1987; 195(2):273-87. DOI: 10.1016/0022-2836(87)90649-8. View

4.
Hui G, Siddiqui W . Serum from Pf195 protected Aotus monkeys inhibit Plasmodium falciparum growth in vitro. Exp Parasitol. 1987; 64(3):519-22. DOI: 10.1016/0014-4894(87)90068-3. View

5.
Burns Jr J, Daly T, Vaidya A, Long C . The 3' portion of the gene for a Plasmodium yoelii merozoite surface antigen encodes the epitope recognized by a protective monoclonal antibody. Proc Natl Acad Sci U S A. 1988; 85(2):602-6. PMC: 279599. DOI: 10.1073/pnas.85.2.602. View